Analysts at London-based multinational bank Barclays are speculating that Boeing’s stocks could be on the uptick to recovery ...

Investment firm Barclays laid out its thoughts for the technology space in 2025 in a research note on Thursday. Read for more ...

Barclays analyst Peter Lawson maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $105.00.

Fintel reports that on January 9, 2025, Barclays downgraded their outlook for Harmonic (NasdaqGS:HLIT) from Overweight to ...

In a report released today, Seth Sigman from Barclays maintained a Hold rating on Five Below (FIVE – Research Report), with a price target of ...

Fintel reports that on January 8, 2025, Barclays upgraded their outlook for Tapestry (NYSE:TPR) from Equal-Weight to ...

Financial analysts at Barclays have upgraded Boeing (BA) to Overweight, citing improved balance sheet, higher free cash flow, ...

The bank – the largest in the US with more than 300,000 employees worldwide – is expected to announce the change in the next ...

A record number of activist shareholders mounted campaigns at global companies in 2024, a Barclays report showed, as their pressure tactics produced strong returns, and further growth is likely ...

U.S. stocks rebounded sharply on Friday after a string of losses in December and the first few sessions of the new year, when ...